Literature DB >> 31358469

Enantiomeric 4'-Truncated 3-deaza-1',6'-isoneplanocins: Synthesis and antiviral properties including Ebola.

Chong Liu1, Rachel Coleman1, Ashley Archer1, Islam Hussein2, Terry L Bowlin2, Qi Chen3, Stewart W Schneller4.   

Abstract

Enantiomeric 3-deaza-1',6'-isoneplanocins (C-3 unsubstituted 7a/7b and C-3 with a bromine 8a/8b) lacking the 4'-hydroxymethyl as mechanistically designed anti-viral targets have been prepared by utilizing the Ullmann reaction. Anti-Ebola properties were found for the D-like 7a and 8a and L-like 8b. All four products showed effects against human cytomegalovirus while D-like 7a/8a affected measles; 7a was effective versus norovirus and 8a inhibited Pichinde. Both 7a and 8a produced SAHase inhibitory effects. However, the anti-EBOV activity of 7a and 8a cannot be readily correlated with this observation due with their contrasting IC50 values (8a > 7a). It is to be noted that 7b showed no effects on this enzyme and 8b was minimally inhibitory. These results offer preliminary insight into the differing mechanisms of action of D- and L- like structures and enlighten structural features to guide additional antiviral agent pursuit in the isoneplanocin series.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Deazaisoneplanocin; Carbocyclic nucleosides; Ebola; HCMV; Measles; Norovirus; Pichinde virus

Year:  2019        PMID: 31358469     DOI: 10.1016/j.bmcl.2019.07.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  New Derivatives of 5-Substituted Uracils: Potential Agents with a Wide Spectrum of Biological Activity.

Authors:  Vasily A Kezin; Elena S Matyugina; Mikhail S Novikov; Alexander O Chizhov; Robert Snoeck; Graciela Andrei; Sergei N Kochetkov; Anastasia L Khandazhinskaya
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

2.  5'-Nor-3-Deaza-1',6'-Isoneplanocin, the Synthesis and Antiviral Study.

Authors:  Qi Chen; Stewart W Schneller; Chong Liu; Kathryn L Jones; Tyler Singer
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.